Teladoc Health Inc’s recent filing unveils that its CHIEF STRATEGY OFFICER Trencher Daniel unloaded Company’s shares for reported $13210.0 on Apr 17 ’24. In the deal valued at $13.21 per share,1,000 shares were sold. As a result of this transaction, Trencher Daniel now holds 26,192 shares worth roughly $ 0.34 million.
Then, Nanis Nikolaos P. sold 461 shares, generating $6,599 in total proceeds. Upon selling the shares at $14.31, the Chief Technology Officer now owns 70,621 shares.
Before that, Geshuri Arnnon sold 7,500 shares. Teladoc Health Inc shares valued at $112,950 were divested by the CHIEF PEOPLE OFFICER at a price of $15.06 per share. As a result of the transaction, Geshuri Arnnon now holds 38,470 shares, worth roughly $0.5 million.
Cantor Fitzgerald initiated its Teladoc Health Inc [TDOC] rating to an Overweight in a research note published on February 29, 2024; the price target was $22. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late February with a ‘”a Market perform”‘ rating. DA Davidson also remained covering TDOC and has decreased its forecast on January 17, 2024 with a “Neutral” recommendation from previously “Buy” rating. Barclays started covering the stock on January 03, 2024. It rated TDOC as “an Overweight”.
Price Performance Review of TDOC
On Friday, Teladoc Health Inc [NYSE:TDOC] saw its stock fall -1.52% to $12.98. Over the last five days, the stock has lost -8.66%. Teladoc Health Inc shares have fallen nearly -39.77% since the year began. Nevertheless, the stocks have fallen -53.76% over the past one year. While a 52-week high of $30.41 was reached on 01/02/24, a 52-week low of $12.93 was recorded on 04/19/24. SMA at 50 days reached $15.69, while 200 days put it at $19.51. A total of 5.49 million shares were traded, compared to the trading of 4.04 million shares in the previous session.
Levels Of Support And Resistance For TDOC Stock
The 24-hour chart illustrates a support level at 12.85, which if violated will result in even more drops to 12.71. On the upside, there is a resistance level at 13.12. A further resistance level may holdings at 13.26. The Relative Strength Index (RSI) on the 14-day chart is 28.63, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.64%. Stochastics %K at 6.85% indicates the stock is a buying.
The most recent change occurred on April 12, 2023 when Stephens began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $25 price target.
